Pavillion Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pavillion capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pavillion Capital Today - Breaking & Trending Today

Circle Pharma Raises $66M in Series C Financing


Circle Pharma Raises $66M in Series C Financing
Circle Pharma, Inc., a South San Francisco, Calif.-based macrocycle drug discovery and development company focused on intractable cancer targets, raised $66m in Series C financing.
The round was co-led by The Column Group and Nextech Invest with participation from Pandect Bioventures, together with new investors including Euclidean Capital, Pavillion Capital, Hartford HealthCare Endowment and Eli Lilly and Company.
The company intends to use the funds to advance its wholly owned cyclin-targeted programs towards the clinic, with potential applications in Rb-dysregulated cancers such as small cell lung cancer and cyclin E dependent malignancies, including ovarian cancer. In addition, Circle Pharma will apply its macrocycle platform to other precision oncology targets that have a clear therapeutic rationale but are considered undruggable with small molecules. ....

Davidj Earp , Eli Lilly , Circle Pharma Inc , Column Group , Circle Pharma , South San Francisco , Nextech Invest , Pandect Bioventures , Euclidean Capital , Pavillion Capital , Hartford Healthcare Endowment , எலி லில்லி , வட்டம் பார்மா இன்க் , நெடுவரிசை குழு , வட்டம் பார்மா , தெற்கு சான் பிரான்சிஸ்கோ , னெக்ஷ்ட்டேச் முதலீடு , பெவிலியன் மூலதனம் ,